The estimated Net Worth of John Hlywak is at least $2.13 Million dollars as of 15 December 2008. John Hlywak owns over 3,000 units of Inmode Ltd stock worth over $1,719,491 and over the last 21 years John sold INMD stock worth over $414,750.
John has made over 16 trades of the Inmode Ltd stock since 2004, according to the Form 4 filled with the SEC. Most recently John bought 3,000 units of INMD stock worth $18,450 on 15 December 2008.
The largest trade John's ever made was selling 24,000 units of Inmode Ltd stock on 15 August 2005 worth over $213,600. On average, John trades about 3,415 units every 60 days since 2003. As of 15 December 2008 John still owns at least 101,745 units of Inmode Ltd stock.
You can see the complete history of John Hlywak stock trades at the bottom of the page.
John's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at Inmode Ltd have traded over $6,777,953 worth of Inmode Ltd stock and bought 2,728,596 units worth $21,820,912 . The most active insiders traders include Peter R Kellogg, Capital Partners, L.P.Sagar..., and & Mcbaine Capital Managemen.... On average, Inmode Ltd executives and independent directors trade stock every 14 days with the average trade being worth of $289,649. The most recent stock trade was executed by Yvonne Thornton on 2 July 2012, trading 500 units of INMD stock currently worth $6,895.
inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and contraction. lumecca: broad spectrum pulsed light for rejuvenation of photo-damaged skin in a wide variety of skin types. diolaze: ultra fast diode hair removal featuring simultaneous 3pc (pre, parallel, and post cooling) technology and state of the art pulsing and power. bodyfx: non-invasive body contouring for buttocks, abdomen, flanks and thighs with a.c.e. technology
Inmode Ltd executives and other stock owners filed with the SEC include: